The combination of PTL with the PI3K inhibitor wortmannin or the mTOR inhibitor rapamycin showed significant toxicity against AML stem cells, both in vitro using patient samples and in mouse models (Pei et al., 2016; Hassane et al., 2010). This evidence concerns the gene MTOR and acute myeloid leukemia.